Send mail to Author

Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   __     ___     _    _    _    _     _____    __   __  
 \ \\/ //   / _ \\  | || | || | || | ||  /  ___||  \ \\/ // 
  \   //   / //\ \\ | || | || | || | || | // __     \ ` //  
  / . \\  |  ___  ||| \\_/ || | \\_/ || | \\_\ ||    | ||   
 /_//\_\\ |_||  |_|| \____//   \____//   \____//     |_||   
 `-`  --` `-`   `-`   `---`     `---`     `---`      `-`'
 


Back to frontdoor view

OPUS4 Logo